Elevage Medical Technologies
3308 Rogers Rd Unit 6101, Austin, Texas, 78758, United States
Overview
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Elucid | Sep 2026Participated | $55 MSeries D | |
Nervonik | Apr 2026Participated | $53 MSeries B | |
Imperative Care | Mar 2026Led | $100 MOther Equity | |
Nuclera | Jan 2026Led | $12 MSeries C | |
Biobeat | Dec 2025Led | $50 MSeries B | |
Galvanize Therapeutics | Sep 2025Participated | $100 MSeries C | |
SetPoint Medical | Aug 2025Led | $140 MSeries D | |
FIRE1 | Jan 2025Led | $120 MOther Equity | |
Nuclera | Oct 2024Led | $77 MSeries C | |
Moximed | Aug 2024Led | $61 MSeries D | |
Elucid | Nov 2023Led | $80 MSeries C | |
Elucid | Sep 2026Participated | $55 MSeries D | |
Nervonik | Apr 2026Participated | $53 MSeries B | |
Imperative Care | Mar 2026Led | $100 MOther Equity | |
Nuclera | Jan 2026Led | $12 MSeries C | |
Biobeat | Dec 2025Led | $50 MSeries B | |
Galvanize Therapeutics | Sep 2025Participated | $100 MSeries C | |
SetPoint Medical | Aug 2025Led | $140 MSeries D | |
FIRE1 | Jan 2025Led | $120 MOther Equity | |
Nuclera | Oct 2024Led | $77 MSeries C | |
Moximed | Aug 2024Led | $61 MSeries D | |
Elucid | Nov 2023Led | $80 MSeries C |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series B | 1 | 1 |
| Series C+ | 5 | 2 |
| Other Equity | 2 | 0 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Nov '23 | 1 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 1 |
| Sep '24 | 0 |
| Oct '24 | 1 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 1 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 1 |
| Sep '25 | 1 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 1 |
| Jan '26 | 1 |
| Feb '26 | 0 |
| Mar '26 | 1 |
| Apr '26 | 1 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 1 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 11 |
| Data, Analytics & IT | 3 |
| Hardware & Robotics | 1 |
| Manufacturing | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 1 |
| $25M-$50M | 0 |
| $50M-$100M | 6 |
| $100M-$250M | 4 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 8 |
| Europe | 3 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Ally Bridge Group | 4 |
| New Enterprise Associates | 3 |
| Catalio Capital Management | 2 |
| G. K. Goh | 2 |
| Gilde Healthcare | 2 |
| Gilmartin Capital | 2 |
| Longaeva | 2 |
| Morgenthaler Ventures | 2 |
| Norwest Venture Partners | 2 |
| ShangBay Capital | 2 |
| Abbott | 1 |
| Action Potential Venture Capital | 1 |
| Advent Life Sciences | 1 |
| Amzak Health | 1 |
| Andera Partners | 1 |
| Apple Tree Partners | 1 |
| Ascendum Capital | 1 |
| Bain Capital Life Sciences | 1 |
| Boston Scientific | 1 |
| British Business Bank | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 8 | 73% |
| Participating | 3 | 27% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 4 | 50% |
| Co-led | 4 | 50% |
Team
Managing Director
Bord of Directors